GI Innovation, Inc. (358570.KQ)
KRW 9790.0
(-4.39%)
KRW 9790.0
(-4.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -55.49 Billion KRW | 30.49% |
| 2022 | -79.83 Billion KRW | 47.04% |
| 2021 | -150.74 Billion KRW | -98.52% |
| 2020 | -75.93 Billion KRW | -54.35% |
| 2019 | -49.19 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -10.2 Billion KRW | 29.16% |
| 2024 Q1 | -14.4 Billion KRW | -24.29% |
| 2023 Q4 | -11.58 Billion KRW | -9.6% |
| 2023 Q3 | -10.57 Billion KRW | 48.75% |
| 2023 FY | -55.49 Billion KRW | 30.49% |
| 2023 Q2 | -20.62 Billion KRW | -62.29% |
| 2023 Q1 | -12.71 Billion KRW | 63.86% |
| 2022 Q2 | -14.93 Billion KRW | -14.89% |
| 2022 FY | -79.83 Billion KRW | 47.04% |
| 2022 Q4 | -35.16 Billion KRW | -110.23% |
| 2022 Q3 | -16.72 Billion KRW | -11.97% |
| 2022 Q1 | -13 Billion KRW | -23.89% |
| 2021 FY | -150.74 Billion KRW | -98.52% |
| 2021 Q4 | -10.49 Billion KRW | 45.34% |
| 2021 Q3 | -19.19 Billion KRW | 0.0% |
| 2020 FY | -75.93 Billion KRW | -54.35% |
| 2019 FY | -49.19 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HLB Co., Ltd. | -189.07 Billion KRW | 70.65% |
| iNtRON Biotechnology, Inc. | -9.69 Billion KRW | -472.387% |
| BINEX Co., Ltd. | 4.67 Billion KRW | 1288.146% |
| Bioneer Corporation | -10.58 Billion KRW | -424.182% |
| Anterogen.Co.,Ltd. | -2.84 Billion KRW | -1853.475% |
| MEDIPOST Co., Ltd. | 5.83 Billion KRW | 1050.262% |
| CrystalGenomics, Inc. | -48.92 Billion KRW | -13.433% |
| Helixmith Co., Ltd | -64.08 Billion KRW | 13.408% |
| Chabiotech Co.,Ltd. | -8.43 Billion KRW | -558.21% |
| Medy-Tox Inc. | 9.75 Billion KRW | 668.885% |
| Peptron, Inc. | -15.92 Billion KRW | -248.547% |
| Amicogen, Inc. | -23.28 Billion KRW | -138.291% |
| Genexine, Inc. | -66.87 Billion KRW | 17.015% |
| HLB Therapeutics Co.,Ltd. | -2.3 Billion KRW | -2310.577% |
| LegoChem Biosciences, Inc. | -73.7 Billion KRW | 24.705% |
| ALTEOGEN Inc. | -3.37 Billion KRW | -1545.883% |
| PharmaResearch Co., Ltd. | 76.55 Billion KRW | 172.494% |
| SillaJen, Inc. | -20.36 Billion KRW | -172.447% |
| JETEMA, Co., Ltd. | 13.96 Billion KRW | 497.362% |
| OliX Pharmaceuticals,Inc | -19.1 Billion KRW | -190.526% |
| Genomictree Inc. | -8.75 Billion KRW | -533.795% |
| MedPacto, Inc. | -35.32 Billion KRW | -57.1% |
| D&D Pharmatech | 3.93 Billion KRW | 1510.728% |
| EASY BIO,Inc. | 15.54 Billion KRW | 457.026% |